Skip to main content
Clinical Trials/NCT06093919
NCT06093919
Completed
Not Applicable

Study of Prevalence of Eating Disorder in Liver Transplant Patients

Centre Hospitalier Henri Laborit2 sites in 1 country118 target enrollmentFebruary 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Eating Disorders
Sponsor
Centre Hospitalier Henri Laborit
Enrollment
118
Locations
2
Primary Endpoint
Prevalence of binge eating disorder in liver transplant patients
Status
Completed
Last Updated
last year

Overview

Brief Summary

The main goal of this observational study is to measure the prevalence of binge eating disorder in liver transplant patients by evaluating the responses to the Bulimia Test.

Secondary objectives of the study are to:

  • Determine the prevalence of binge eating disorders in liver transplant patients following alcoholic cirrhosis, evaluated by the Bulimia Test;
  • Study the association between the presence of eating disorder behaviours and liver damage : hepatic steatosis and fibrosis determined by Fibroscan (Transient elastography and controlled attenuation parameter)
  • Study the association between presence of eating disorder behaviours and alcohol use disorder, measured by Alcohol Use Disorders Identification Test-Consumption
Registry
clinicaltrials.gov
Start Date
February 12, 2024
End Date
August 14, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • over 18 years old
  • had a liver transplant and followed at University Hospital of Poitiers
  • responded to the Bulimia Test-Revised and to the Alcohol Use Disorders Identification Test-Consumption
  • had a Fibroscan within the year

Exclusion Criteria

  • Patient without Fibroscan and not responded to both scale : Bulimia Test-Revised and Alcohol Use Disorders Identification Test-Consumption

Outcomes

Primary Outcomes

Prevalence of binge eating disorder in liver transplant patients

Time Frame: 1 year

The prevalence is defined as the percentage of liver transplant patients with a score higher than 88 on the Bulimia Test-Revised. The Bulimia Test-Revised is a validated test. It is a 36 item self-report questionnaire to assess the presence of bulimic symptoms. Scores range from 29-140 with those greater than 104 being indicative of bulimia nervosa.

Secondary Outcomes

  • Correlation between the BulimiaTest-Revised score and liver damage determined by the Fibroscan(1 year)
  • Prevalence for binge eating disorder in liver transplant patients following alcoholic cirrhosis(1 year)
  • Correlation between the Bulimia-Test score and the Alcohol Use Disorders Identification Test-Consumption score(1 year)

Study Sites (2)

Loading locations...

Similar Trials